BioCentury
ARTICLE | Clinical News

Fortical Injection salmon calcitonin: Phase III trials in the U.S. and U.K.

August 26, 1996 7:00 AM UTC

Unigene Laboratories Inc. (UGNE), Fairfield, N.J. Product: Fortical Injection salmon calcitonin Indication: Osteoporosis Status: UGNE began pivotal Phase III trials in the U.S. and U.K. for bioequiva...